Thematic Investing Channel Biotech ETFs Jump: Keep an Eye on XBI, IBB & SBIO By Frank HolmanJune 18, 2019
Innovative ETFs Channel Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal By Max ChenJune 17, 2019
Innovative ETFs Channel Don’t Forget Fintech ETFs After the Industry Just Notched $117B in Deals By Ben HernandezJune 10, 2019
Innovative ETFs Channel Big Venture Capitalist Bets Could Give Fintech ETFs a Boost By Ben HernandezMay 29, 2019
Thematic Investing Channel Tech ETFs: Inventory Issues Could Weigh on Sector By Todd ShriberMay 17, 2019
Beyond Basic Beta Channel Biotech ETFs Could Use Some Mergers & Acquisitions By Tom LydonMay 17, 2019
Core Equity Channel Ahead of Apple Earnings, Investors Rush Into Tech ETFs By Tom LydonApril 30, 2019
Thematic Investing Channel Biotech ETFs: Destinations For Investing in Innovation By Brenton GarenApril 18, 2019
Innovative ETFs Channel Healthcare, Biotech ETFs Plunge on Mounting Political Pressures By Max ChenApril 18, 2019
Beyond Basic Beta Channel Among Tech ETFs, Chip Funds Still Look Attractive By Todd ShriberApril 4, 2019
Relative Value Channel FIS Purchase of Worldpay Could Put Fintech ETFs in Play By Ben HernandezMarch 18, 2019
Innovative ETFs Channel Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Thematic Investing Channel Biotech ETFs Conquers an Important Technical Hurdle By Brenton GarenMarch 6, 2019
Core Equity Channel Traders Suggest Treading Carefully With Biotech ETFs By Brenton GarenJanuary 15, 2019
